Drug Discovery · Burlingame, CA · Founded 2015 · Privately Held (backing)
Operator of a biotech company intended to work for the development of a new class of flexible, extendible, and cooperatively binding therapeutics and diagnostics. Hinge Bio is based in Burlingame, CA and was founded in 2015. It was valued at $46 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $66.8 million across 4 recorded rounds; the latest was a $30.6 million early-stage round in Dec 2024.
PMV mark · valuation
$46.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$66.8M
Last round
Early Stage VC
Dec 2024
No prints on record
No secondary trades in Hinge Bio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hinge Bio with a free account
·The complete investor list: 13 names
·Watch Hinge Bio: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Hinge Bio stock.
